Recent Drug Discovery Research for February 2023
Lyme Disease - Drug Pipeline Landscape, 2023
Topics: Lyme Disease, Drug Discovery, Clinical Trial
| Lassa Fever - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, Clinical Trial
| Acromegaly - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, Clinical Trial
| Hepatitis D (HDV) - Drug Pipeline Landscape, 2023
Topics: Hepatitis, Drug Discovery, Clinical Trial
| Parkinson's Disease - Drug Pipeline Landscape, 2023
Topics: Parkinson's Disease, Drug Discovery
| Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, CNS/Neurology
| Diabetic Nephropathy - Drug Pipeline Landscape, 2023
Topics: Diabetes, Drug Discovery
| Hypertension - Drug Pipeline Landscape, 2023
Topics: Hypertension, Drug Discovery
| Irritable Bowel Syndrome - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, Gastrointestinal
| Diabetic Neuropathy - Drug Pipeline Landscape, 2023
Topics: Diabetes, Drug Discovery
| Diabetic Retinopathy - Drug Pipeline Landscape, 2023
Topics: Diabetes, Drug Discovery
| Dysmenorrhea - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, Women's Health, Obstetrics/Gynecology
| Neutropenia - Drug Pipeline Landscape, 2023
Topics: Drug Discovery
| Interstitial Cystitis - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, Urology
| Migraine - Drug Pipeline Landscape, 2023
Topics: Pain, Drug Discovery, CNS/Neurology
| Male Hypogonadism - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, Men's Health
| Angina Pectoris - Drug Pipeline Landscape, 2023
Topics: Drug Discovery, Cardiovascular
| Venous Thromboembolism - Drug Pipeline Landscape, 2023
Topics: Drug Discovery
| Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Non-Alcoholic Fatty Liver Disease (NAFLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Topics: Drug Discovery, Clinical Trial
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Topics: Drug Discovery, Clinical Trial
| Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Topics: Influenza, Drug Discovery, Clinical Trial
| Drug Discovery Informatics
Topics: Informatics, Drug Development, Drug Discovery
Regions: Global
| COVID-19 Clinical Trials Market Research Report by Product (Therapeutics and Vaccines), Phase, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030
Topics: Drug Development, COVID-19/Coronavirus, Research & Development, Vaccines, Drug Discovery, Clinical Trial
Regions: Russia, Ukraine, United States
| Global Acne Therapeutics Market - 2023-2030
Topics: COVID-19/Coronavirus, Prescription Drugs, Drug Discovery, Dermatology
Regions: Global
| Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2023-2029
Topics: Cancer Treatment, Manufacturing, Packaging & Detailing, Drug Discovery, Oncology/Hematology
Regions: Global
| 2023 Global: Antipsychotic Drugs - Innovative Markets Forecast (2029) report
Topics: Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
Regions: Global
| 2023 Global: Artificial Intelligence (Ai) In Drug Discovery - Innovative Markets Forecast (2029) report
Topics: Drug Development, Internet of Things IoT, Drug Discovery
Regions: Global
| APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027
Topics: Genomics, Research & Development, Drug Development, Microarray , Next Generation Sequencing, Drug Discovery
Regions: Asia
| Asia-Pacific Laboratory Animal Diets Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discover
Topics: Drug Development, Regenerative Medicine, Personalized Medicine, COVID-19/Coronavirus, Laboratories, Drug Discovery
Regions: Asia, Oceania
| Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Hypertension, Drug Discovery
| Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Multiple Sclerosis (MS), Drug Discovery
| Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Huntington's, Drug Discovery
| Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Ophthalmology
| Myocardial Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Cardiovascular
| Metachromatic Leukodystrophy (MLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Canavan Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Wound Care, Drug Discovery, Medical Adhesives & Sealants
| Peptic Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Ornithine-Transcarbamylase Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Usher Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Neurofibromatoses Type I (Von Recklinghausen’s Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Wilson Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Blood Diseases, Drug Discovery, Renal
| ANX005 Emerging Drug Insight and Market Forecast – 2032
Topics: Drug Discovery
| Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Topics: Prescription Drugs, Drug Discovery, Clinical Trial, CNS/Neurology, Behavioral Health
Regions: Global
| Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Topics: Prescription Drugs, Drug Discovery, Clinical Trial
Regions: Global
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
